Fun fact: Mounjaro has been proven to be much more effective for weight loss than Saxenda, which is actually approved by the FDA as a weight loss injection.
To know more about Mounjaro, keep on reading the article. If you’re weighing the pros and cons of Mounjaro and other weight loss medications, we suggest you consult with us at My Concierge MD.
What is Mounjaro?
Mounjaro (tirzepatide) is an injection approved by the FDA for treating patients with type 2 diabetes. It is a GLP-1 receptor agonist. GLP-1 receptor agonist is a medicine component that mimics glucagon-like peptide-1 (GLP-1), a hormone in the intestine. It is used for improving blood sugar, i.e., glucose levels in adults with type 2 diabetes, with the right kind of exercise and diet.
Is Mounjaro approved for weight loss?
Although Mounjaro is not approved by the FDA as a weight loss drug, it is possible that it can cause weight loss. It could be said that FDA may approve this drug for weight loss in the future.
Although Mounjaro hasn’t been approved by the FDA yet, there’s another drug from the same family that has been recently approved for weight management. It’s called Zepbound (Tirzepatide).
How quickly can you lose weight with Mounjaro?
A study suggested that people who kept taking tirzepatide for 72 weeks (a year and a half) lost 15% of their body weight on average. The duration depends on various pointers like age, gender, diet, lifestyle choice, etc.
How effective is Mounjaro for weight loss?
Clinical trials suggest that Mounjaro is somewhat effective in causing weight loss in people who take it. A study conducted by Eli Lilly amongst participants achieved a total average weight loss of 26.6% over 84 weeks.
Another Cleveland Clinic study showed that 2500 obese adults taking 5 mg of Mounjaro for 72 weeks lost 15% of their body weight [1].
